Overview
This video features Dr. Paul Marik, a critical care specialist, describing his breakthrough protocol for treating sepsis and septic shock, conditions that are among the leading causes of death in hospitals worldwide. Dr. Marik shares how he developed a treatment combining intravenous vitamin C, thiamine, and corticosteroids, which he and his team observed to dramatically improve patient outcomes, including rapid recovery from multi-organ failure.
Dr. Marik recounts his initial experience administering vitamin C to a critically ill patient in 2016, noting the unexpected and remarkable recovery. This led to repeated use of the protocol with consistent positive results, supported by observations from nurses who witnessed fewer deaths and less need for renal replacement therapy. The protocol involves early administration of 1.5 grams of intravenous vitamin C every six hours, 200 mg of thiamine every 12 hours, and 50 mg of hydrocortisone every six hours, alongside standard antibiotics.
The video also addresses the biological rationale for vitamin C’s role in sepsis treatment. Humans, unlike most animals, cannot produce vitamin C naturally and require it as an essential stress hormone. Vitamin C acts as a potent antioxidant, anti-inflammatory agent, and supports cellular and mitochondrial function, which are critical in combating the systemic inflammation and organ damage caused by sepsis.
Despite the promising clinical observations, Dr. Marik discusses significant resistance from the medical establishment and challenges in gaining acceptance for the protocol. He describes a pivotal event at a medical conference where a major clinical trial (the Vitamins trial) was presented with negative results, but with critical flaws such as delayed administration of vitamin C (often 18 hours or more after hospital admission), which he and colleagues argue invalidated the study’s conclusions. Dr. Marik and Dr. Pierre Kory, who also supports the protocol, express concerns about trial designs that fail to reflect the time-sensitive nature of sepsis treatment and suggest some trials may be intentionally designed to fail.
The video highlights the ethical dilemma faced by nurses who refused to participate in randomized controlled trials that would withhold the vitamin C protocol from some patients, believing it would be unethical given the observed benefits. Dr. Marik emphasizes the importance of early treatment and criticizes delays in therapy as detrimental.
Dr. Marik and Dr. Kory discuss the broader context of medical and scientific corruption, including the suppression of inexpensive, repurposed treatments like vitamin C and ivermectin in favor of expensive patented drugs. They call for increased awareness, patient advocacy, and well-designed clinical trials to validate and implement the protocol more widely.
Key Points of the Protocol
- Vitamin C: 1.5 grams intravenously every 6 hours, infused over 20 minutes.
- Thiamine (Vitamin B1): 200 mg intravenously every 12 hours.
- Hydrocortisone (Corticosteroid): 50 mg intravenously every 6 hours.
- Early administration: Treatment should begin as soon as sepsis is suspected, ideally within 6 hours of emergency department triage.
- Combined use: The synergy between vitamin C and corticosteroids is critical for effectiveness.
Challenges and Controversies
- Resistance from hospitals and medical authorities despite observed clinical success.
- Negative clinical trials criticized for delayed treatment timing and flawed design.
- Ethical concerns about randomized controlled trials withholding the protocol from patients.
- Allegations of systemic corruption favoring expensive patented drugs over cheap, repurposed treatments.
- Calls for patient and family advocacy to request early treatment with the protocol.
Biological Basis for Vitamin C in Sepsis
Dr. Marik explains that vitamin C is a vital stress hormone produced by most animals but not by humans. It functions as a powerful antioxidant, anti-inflammatory agent, and supports mitochondrial energy metabolism and collagen synthesis. These properties help protect cells from bacterial toxins and reduce the systemic inflammation characteristic of sepsis.
Source Information
This content is based on a 42-minute video interview with Dr. Paul Marik, hosted on the Rumble platform and associated with the FLCCC (Front Line COVID-19 Critical Care Alliance). The video includes detailed discussion of the development, clinical application, and scientific and political challenges related to Dr. Marik’s sepsis and septic shock protocol. It also features commentary from Dr. Pierre Kory, a collaborator and advocate for repurposed treatments. The transcript reveals firsthand accounts, clinical observations, and critical perspectives on medical research practices and institutional resistance.
For more information, the video is available at: https://rumble.com/v1lfbsp-life-saving-dr.-paul-marik-s-sepsis-and-septic-shock-protocol-vitamin-c-play.html
